140 related articles for article (PubMed ID: 18848662)
1. Synthesis and evaluation of novel radioiodinated nicotinamides for malignant melanoma.
Liu X; Pham TQ; Berghofer P; Chapman J; Greguric I; Mitchell P; Mattner F; Loc'h C; Katsifis A
Nucl Med Biol; 2008 Oct; 35(7):769-81. PubMed ID: 18848662
[TBL] [Abstract][Full Text] [Related]
2. Preparation and biologic evaluation of a novel radioiodinated benzylpiperazine, 123I-MEL037, for malignant melanoma.
Pham TQ; Berghofer P; Liu X; Greguric I; Dikic B; Ballantyne P; Mattner F; Nguyen V; Loc'h C; Katsifis A
J Nucl Med; 2007 Aug; 48(8):1348-56. PubMed ID: 17631542
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of ¹²³/¹³¹I-Iochlonicotinamide as a novel SPECT probe for malignant melanoma.
Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
Bioorg Med Chem; 2015 May; 23(9):2261-9. PubMed ID: 25800432
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel radioiodinated benzamides for malignant melanoma.
Pham TQ; Greguric I; Liu X; Berghofer P; Ballantyne P; Chapman J; Mattner F; Dikic B; Jackson T; Loc'h C; Katsifis A
J Med Chem; 2007 Jul; 50(15):3561-72. PubMed ID: 17602544
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of a novel radioiodinated phenylacetamide and its homolog as theranostic agents for malignant melanoma.
Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
Eur J Pharm Sci; 2016 Jan; 81():201-9. PubMed ID: 26517961
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of a novel Al(18)F-NOTA-BZA conjugate for melanin-targeted imaging of malignant melanoma.
Chang CC; Chang CH; Lo YH; Lin MH; Shen CC; Liu RS; Wang HE; Chen CL
Bioorg Med Chem Lett; 2016 Aug; 26(16):4133-9. PubMed ID: 27445169
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma.
Michelot JM; Moreau MF; Labarre PG; Madelmont JC; Veyre AJ; Papon JM; Parry DF; Bonafous JF; Boire JY; Desplanches GG
J Nucl Med; 1991 Aug; 32(8):1573-80. PubMed ID: 1869982
[TBL] [Abstract][Full Text] [Related]
8. Targeted radiotherapy of pigmented melanoma with
Xu X; Yuan L; Gai Y; Liu Q; Yin L; Jiang Y; Wang Y; Zhang Y; Lan X
J Exp Clin Cancer Res; 2018 Dec; 37(1):306. PubMed ID: 30537980
[TBL] [Abstract][Full Text] [Related]
9. A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinylaminoethyl)4-iodobenzamide.
John CS; Bowen WD; Saga T; Kinuya S; Vilner BJ; Baumgold J; Paik CH; Reba RC; Neumann RD; Varma VM
J Nucl Med; 1993 Dec; 34(12):2169-75. PubMed ID: 8254405
[TBL] [Abstract][Full Text] [Related]
10. Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization.
Eisenhut M; Hull WE; Mohammed A; Mier W; Lay D; Just W; Gorgas K; Lehmann WD; Haberkorn U
J Med Chem; 2000 Oct; 43(21):3913-22. PubMed ID: 11052796
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma.
Chezal JM; Papon J; Labarre P; Lartigue C; Galmier MJ; Decombat C; Chavignon O; Maublant J; Teulade JC; Madelmont JC; Moins N
J Med Chem; 2008 Jun; 51(11):3133-44. PubMed ID: 18481842
[TBL] [Abstract][Full Text] [Related]
12. 99mTc(I)/Re(I) tricarbonyl complexes for in vivo targeting of melanotic melanoma: Synthesis and biological evaluation.
Moura C; Gano L; Mendes F; Raposinho PD; Abrantes AM; Botelho MF; Santos I; Paulo A
Eur J Med Chem; 2012 Apr; 50():350-60. PubMed ID: 22397924
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma.
Wu SY; Huang SP; Lo YC; Liu RS; Wang SJ; Lin WJ; Shen CC; Wang HE
Biomed Res Int; 2014; 2014():912498. PubMed ID: 25254219
[TBL] [Abstract][Full Text] [Related]
14. Examination of four 123I-labeled piperidine-based sigma receptor ligands as potential melanoma imaging agents: initial studies in mouse tumor models.
Waterhouse RN; Chapman J; Izard B; Donald A; Belbin K; O'Brien JC; Collier TL
Nucl Med Biol; 1997 Aug; 24(6):587-93. PubMed ID: 9316089
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors.
John CS; Gulden ME; Li J; Bowen WD; McAfee JG; Thakur ML
Nucl Med Biol; 1998 Apr; 25(3):189-94. PubMed ID: 9620622
[TBL] [Abstract][Full Text] [Related]
16. Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracer.
Rbah-Vidal L; Vidal A; Besse S; Cachin F; Bonnet M; Audin L; Askienazy S; Dollé F; Degoul F; Miot-Noirault E; Moins N; Auzeloux P; Chezal JM
Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1449-61. PubMed ID: 22707183
[TBL] [Abstract][Full Text] [Related]
17. Radioiodination and preclinical evaluation of 4-benzyl-1-(3-[
Sadeghzadeh M; Alirezapour B; Charkhlooie GA; Baghery MK; Khorouti A
Ann Nucl Med; 2017 May; 31(4):335-346. PubMed ID: 28315150
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma.
Joyal JL; Barrett JA; Marquis JC; Chen J; Hillier SM; Maresca KP; Boyd M; Gage K; Nimmagadda S; Kronauge JF; Friebe M; Dinkelborg L; Stubbs JB; Stabin MG; Mairs R; Pomper MG; Babich JW
Cancer Res; 2010 May; 70(10):4045-53. PubMed ID: 20442292
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and comparative biodistribution study of a new series of p-iodine-125 benzamides as potential melanoma imaging agents.
Moins N; Papon J; Seguin H; Gardette D; Moreau MF; Labarre P; Bayle M; Michelot J; Gramain JC; Madelmont JC; Veyre A
Nucl Med Biol; 2001 Oct; 28(7):799-808. PubMed ID: 11578901
[TBL] [Abstract][Full Text] [Related]
20. A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.
Froidevaux S; Calame-Christe M; Tanner H; Sumanovski L; Eberle AN
J Nucl Med; 2002 Dec; 43(12):1699-706. PubMed ID: 12468522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
